The reaffirmation of the Hold rating and the maintenance of the price target at $125 by Truist Securities suggests a neutral outlook on Globe Life's stock in the short term. This analysis is based on the assumption that the analyst's views are highly regarded in the market, but since there's no change in the rating or price target, the immediate impact on the stock price is likely to be minimal.